Clinical Trial Update: A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Acthar Gel alone or with tacrolimus to reduce proteinuria in fibrillary glomerulonephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrillary Glomerulonephritis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: NephroNet, Inc. | Conditions: Fibrillary Glomerulonephritis | Phase 4 | Status: UNKNOWN